bpc-157 clinical trial humans safety and the Difference Between an Evidence Gap and a Cover-Up: What the entire human evidence base actually looks like, and the questions to ask next. — WellFounded What Is BPC-157? A Medical

Prudent approach cycles peptides or limits to injury treatment periods rather than indefinite continuous use

This extrapolates from effective rat doses using standard interspecies scaling factors

BMC Neurol (2011) 11:37

Other risk factors that have been suggested to be related to the development of vitamin B 12 deficiency include pernicious anemia and the long-term use of certain drugs such as acid-suppressing medications [79] and metformin [52]

Perceptions of exercise and restless legs syndrome: Results from a nationwide survey

That said, patients with active diabetes or significant metabolic dysfunction should have any investigational peptide protocol reviewed by their endocrinologist or primary care physician alongside their supervising aesthetic medicine provider